Funding for this research was provided by:
Direction Générale de l’offre de Soins
Fondation ARC pour la Recherche sur le Cancer
Fodation de France
Received: 5 October 2020
Accepted: 26 April 2021
First Online: 21 May 2021
: Before PDX establishment, all patients had previously given their verbal informed consent for experimental research on residual tumor tissue available after histopathological analyses.PDX establishment was performed after the approval of the ethics committee of the Institut Curie.Written informed consent was obtained from each patient. The study protocol was approved by the institutional ethics committee.
: All authors gave consent for the publication of the manuscript in <i>Breast Cancer Research</i>.
: The authors declare that they have no competing interests.